Related Experiment Videos
Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis
1Department of Ophthalmology, University of Aberdeen, UK. a.dick@abdn.ac.uk
Journal of Autoimmunity
|August 7, 1998
Summary
Neutralizing tumor necrosis factor-alpha (TNF-alpha) activity in rats with experimental autoimmune uveoretinitis (EAU) protected tissues from destruction. This inhibition suppressed Th1 responses while preserving T cell infiltration and antigen-specific proliferation.
Area of Science:
- Immunology
- Ophthalmology
- Autoimmunity
Background:
- Tumor necrosis factor-alpha (TNF-alpha) plays a critical role in autoimmune diseases.
- Its precise function in the pathogenesis of experimental autoimmune uveoretinitis (EAU) requires further elucidation.
- Understanding TNF-alpha's role is crucial for developing targeted therapies for autoimmune uveitis.
Purpose of the Study:
- To investigate the role of TNF-alpha in EAU by characterizing T cells after TNF-alpha antagonist treatment.
- To determine the impact of TNF-alpha inhibition on T cell phenotype, activation, apoptosis, and function within the retina.
Main Methods:
- Lewis rats with EAU were treated with a p55 TNF-alpha receptor-Ig fusion protein (sTNFr-Ig).
- Retinal T cells were analyzed using flow cytometry for phenotype (OX22 status), activation (OX40, CD25), and apoptosis (Annexin V).
- Lymphocyte reactivity was assessed via proliferation assays and cytokine production (IFN-gamma, IL-4) in response to retinal antigens.
Main Results:
- TNF-alpha neutralization prevented retinal tissue destruction.
- Despite T cell infiltration, activated CD4+ T cells showed reduced OX22low expression, decreased IFN-gamma, and increased IL-4 production.
- Retinal T cells maintained antigen-specific proliferation and had a low apoptotic rate.
Conclusions:
- Inhibiting TNF-alpha activity in EAU protects ocular tissues by suppressing Th1 effector mechanisms.
- This inhibition does not impede T cell infiltration or antigen-specific responses.
- Targeting TNF-alpha represents a potential therapeutic strategy for autoimmune uveitis, mitigating tissue damage while preserving immune surveillance.